COVID POWER PLAYERS: Meet the 14 top drug industry execs who are leading the sprint to develop coronavirus treatments and vaccines in record time
- Drugmakers are racing to find ways to treat and prevent the novel coronavirus through treatments and vaccines.
- Business Insider identified 14 top drug industry executives playing critical roles in responding to the pandemic.
- This group of business leaders are in charge of designing new medicines, testing drugs in humans, pricing, and manufacturing.
- For more stories like this, sign up here for our healthcare newsletter Dispensed.
The coronavirus pandemic has put a spotlight on the pharmaceutical industry.
The past few months have made it clear there isn’t a return to normal without therapeutics or vaccines. While several dozen drug companies are now working on treatments and vaccines, a handful of efforts have leapt to the forefront.
The potential treatments and vaccines, made by drugmakers like Gilead Sciences, Moderna, and Regeneron have ambitious timelines, with the hopes of being available for widespread use later in 2020 or in 2021. Companies, governments, and global nonprofits are spending billions to pull that off.
Business Insider identified 14 top executives that are playing key roles in the hunt for a COVID-19 drug or vaccine. These business leaders will not only guide testing of new medicines, but eventually will figure out how to price …continued .
[Source: Business Insider]